University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic.
Healthc Policy
; 17(4): 15-25, 2022 05.
Article
in English
| MEDLINE | ID: covidwho-1893378
ABSTRACT
Publicly funded research has contributed enormously to many products that were developed in the face of the COVID-19 pandemic. Yet universities' technology transfer practices have failed to ensure that these products are available in low- and middle-income settings. Drawing upon the example of the lipid nanoparticle delivery technology - which was developed in and around the University of British Columbia in Vancouver, BC, and incorporated into the Pfizer/BioNTech COVID-19 vaccine - we show the divide between the university's stated principles to serve global health and technology transfer in practice. We outline three policy actions to realign universities' technology transfer practices in the service of global health.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Technology Transfer
/
COVID-19
Type of study:
Observational study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Healthc Policy
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS